MIIM
CRL icon

Mesirow Institutional Investment Management’s Charles River Laboratories CRL Stock Holding History

Mesirow Institutional Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$366K Sell
1,984
-14,756
-88% -$2.84M 0.03% 126
2024
Q3 		$3.3M Buy
16,740
+3,064
+22% +$637K 0.25% 96
2024
Q2 		$2.83M Buy
+13,676
New +$3.1M 0.25% 94
2023
Q1 		– Sell
-13,940
Closed -$3.04M – 147
2022
Q4 		$3.04M Buy
13,940
+2,305
+20% +$503K 0.4% 80
2022
Q3 		$2.29M Buy
+11,635
New +$2.51M 0.33% 84

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Mesirow Institutional Investment Management's CRL Position: Q4 2024 in Review

Mesirow Institutional Investment Management reduced its Charles River Laboratories (CRL) stake by 88% in Q4 2024, selling an estimated $2.84M and leaving 1,984 shares worth $366K. The position accounts for 0.03% of the portfolio, ranked #126.

Mesirow Institutional Investment Management first reported a position in CRL in Q3 2022 and has held it in 5 quarters since. The position peaked at $3.3M in Q3 2024. 635 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Mesirow Institutional Investment Management held 1,984 shares of Charles River Laboratories worth $366K as of Q4 2024.
  • Mesirow Institutional Investment Management sold 14,756 Charles River Laboratories shares in Q4 2024, an estimated $2.84M.
  • Charles River Laboratories made up 0.03% of Mesirow Institutional Investment Management's portfolio in Q4 2024, its #126 holding.
  • Mesirow Institutional Investment Management first reported a position in Charles River Laboratories in Q3 2022 and has held it in 5 quarters since.
  • Mesirow Institutional Investment Management's Charles River Laboratories position peaked at $3.3M in Q3 2024.
  • 635 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.